Bring the decision. We’ll scope the question.
The scoping call is where screening happens.
Tell us who you are, what is at stake, and what cannot
responsibly continue as-is; we will determine in conversation whether
the Diagnostic is the right instrument.
FOR EXECUTIVES, BOARDS & DILIGENCE TEAMS

Diagnostic scoping call

30 minutes · No fee

A working conversation, not a sales call. We identify the decision at stake, the claim-lines under examination, the organizational context, and whether a four-week determination can answer the actual question.

‍The calibration question: what specific initiative, transaction or commitment can no longer continue as-is without crossing an irreversibility threshold?

- We confirm fit — or tell you it isn't there — on the call
- The answer can be “not the right instrument.”
- If it fits, scope and fixed fee are confirmed.
- Evidence requirements follow after scoping.
- The call is confidential — nothing you disclose leaves the room, whether or not we engage
‍

Request a scoping call →
FOR TEAMS STILL WORKING WITH OKRs

KR Evidence Review

90 minutes · $2,500 fixed · Credited toward the Diagnostic within 30 days

A fixed-scope working session covering one OKRs set  —  testing whether your key results represent the outcomes they claim to represent. This is a named product with a defined output — not open-ended time.
‍
- You submit one objective, its 3–5 KRs, and supporting initiatives 48 hours in advance
- 90-minute session: each KR tested against its claimed outcome it claims
- You receive a written KR Evidence Review memo within 3 business days
- No automatic Diagnostic or implementation engagement.
- Commission the Diagnostic within 30 days and the full fee is credited — the Review becomes its first step
‍

Book a KR Evidence Review →

Engagements are limited to 2–3 concurrent diagnostics. If capacity is full, you'll be offered the next opening rather than a waiting list.

BEFORE YOU BOOK

Three things to know

We may say no
If your situation doesn't warrant the Diagnostic — or if what you need is reassurance rather than an answer — we'll say so. The scoping call exists to prevent bad-fit engagements, not to close them.

The answer can be adverse
The Diagnostic can conclude that the evidence doesn't support the claims. That conclusion arrives in writing, without softening. That is a feature of the product, not a failure of the engagement. If a particular answer is required, do not book.

No next phase is assumed
The products do not create an obligation or an on-ramp you didn't ask for. Where a verdict calls for resolution work, that work scoped and priced separately — and we may advise against it. Nothing is bundled into the call.
‍

Can we keep going?

Control it. Execute it. Stand behind it.
The three tests tell you whether continuation is still defensible.
Governability 
Can we control it under current constraints?
Execution
Can we still enforce the limits?
Legitimacy
Can we still stand behind the decision?